Working… Menu

Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection (PROTECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04344600
Recruitment Status : Recruiting
First Posted : April 14, 2020
Last Update Posted : July 19, 2021
Eiger BioPharmaceuticals
Information provided by (Responsible Party):
Johns Hopkins University